Asim Datye
Impact in
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- PARP inhibition in cancer therapy
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
- Oncology 4
- Cancer Immunotherapy and Biomarkers 2
- CAR-T cell therapy research 1
-
- Hidradenitis Suppurativa and Treatments 2
- Co-authors
- Kobe Chi Yung Yuen (2 shared papers)Edward Ernest Kadel (2 shared papers)Begoña Mellado (1 shared paper)Silke Gillessen (1 shared paper)Charles G. Drake (1 shared paper)Christopher J. Sweeney (1 shared paper)Bogusława Karaszewska (1 shared paper)Jennifer F. Doss (1 shared paper)
- Journals
- Journal of Biopharmaceutical Statistics (1 paper)Journal of the American Academy of Dermatology (1 paper)Clinical and Translational Science (1 paper)Nature Medicine (1 paper)Cancer Medicine (1 paper)
- Partner nations
- SwitzerlandUnited StatesCanada
In The Last Decade
Asim Datye
7 papers receiving 264 citations
Asim Datye's Hit Papers
Peers
Comparison fields: 5 of 33
- Oncology 128
- Pulmonary and Respiratory Medicine 144
- Immunology 69
- Cancer Research 23
- Radiology, Nuclear Medicine and Imaging 23
Countries citing papers authored by Asim Datye
This map shows the geographic impact of Asim Datye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asim Datye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asim Datye more than expected).
Fields of papers citing papers by Asim Datye
This network shows the impact of papers produced by Asim Datye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asim Datye. The network helps show where Asim Datye may publish in the future.
Co-authors
The 25 scholars most cited alongside Asim Datye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial Hit paper breakdown → | 2022 | 201 |
| 2 | 2021 | 46 | |
| 3 | 2022 | 13 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 2 | |
| 6 | 2025 | 1 | |
| 7 | 2024 | 1 |
About Asim Datye
Asim Datye is a scholar working on Oncology, Dermatology, Neurology, Pulmonary and Respiratory Medicine and Surgery, having authored 7 papers that have together received 266 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (2 papers), Hidradenitis Suppurativa and Treatments (2 papers), Neuroblastoma Research and Treatments (2 papers), Colorectal and Anal Carcinomas (2 papers), Prostate Cancer Treatment and Research (2 papers), Radiopharmaceutical Chemistry and Applications (1 paper), Renal and related cancers (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Oncology (128 citations), Pulmonary and Respiratory Medicine (144 citations), Immunology (69 citations), Cancer Research (23 citations) and Radiology, Nuclear Medicine and Imaging (23 citations). Asim Datye has collaborated with scholars based in Switzerland, United States and Canada. Frequent co-authors include Kobe Chi Yung Yuen, Edward Ernest Kadel, Begoña Mellado, Silke Gillessen, Charles G. Drake, Christopher J. Sweeney, Bogusława Karaszewska, Jennifer F. Doss, Karim S. Fizazi and Dana E. Rathkopf. Their work appears in journals such as Journal of Biopharmaceutical Statistics, Journal of the American Academy of Dermatology, Clinical and Translational Science, Nature Medicine and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.